Q4 2022 Holdings
Filed 2023-02-14 | 443 holdings | $191.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Novavax Inc(NVAX) | COM NEW | 670002401 | $83.6K | 8,129 | 0.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $86.2K | 4,166 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $92.0K | 9,113 | 0.0% |
| Cassava Sciences Inc(SAVA) | COM | 14817C107 | $93.8K | 3,175 | 0.0% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $100.9K | 17,102 | 0.1% |
| Immunitybio Inc(IBRX) | COM | 45256X103 | $105.4K | 20,782 | 0.1% |
| Allovir Inc | COM | 019818103 | $107.2K | 20,906 | 0.1% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $107.8K | 17,165 | 0.1% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $110.8K | 125,062 | 0.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $111.6K | 13,896 | 0.1% |
| Blackstone Secd Lending FD(BXSL) | COMMON STOCK | 09261X102 | $112.4K | 5,029 | 0.1% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $113.5K | 2,791 | 0.1% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $113.8K | 18,097 | 0.1% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $114.6K | 19,135 | 0.1% |
| Mersana Therapeutics Inc | COM | 59045L106 | $115.0K | 19,618 | 0.1% |
| Inovio Pharmaceuticals Inc | COM NEW | 45773H201 | $116.8K | 74,903 | 0.1% |
| Codexis Inc(CDXS) | COM | 192005106 | $117.0K | 25,102 | 0.1% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $117.3K | 4,761 | 0.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $117.6K | 10,150 | 0.1% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $117.7K | 13,164 | 0.1% |
| Curevac N V | COM | N2451R105 | $117.8K | 19,535 | 0.1% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $118.0K | 4,729 | 0.1% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $118.3K | 15,342 | 0.1% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $118.4K | 36,100 | 0.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $119.6K | 8,004 | 0.1% |
| Verve Therapeutics Inc | COM | 92539P101 | $119.9K | 6,195 | 0.1% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $119.9K | 13,520 | 0.1% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $120.0K | 51,496 | 0.1% |
| Atai Life Sciences NV | SHS | N0731H103 | $120.2K | 45,184 | 0.1% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $120.4K | 7,078 | 0.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $120.4K | 6,154 | 0.1% |
| Amyris Inc(AMRSEUR) | COM NEW | 03236M200 | $121.8K | 79,585 | 0.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $123.8K | 8,916 | 0.1% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $124.0K | 11,751 | 0.1% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $124.4K | 11,332 | 0.1% |
| Precigen Inc(PGEN) | COM | 74017N105 | $124.5K | 81,912 | 0.1% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $124.7K | 8,423 | 0.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $124.7K | 28,940 | 0.1% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $125.0K | 52,070 | 0.1% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $125.5K | 14,425 | 0.1% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $126.0K | 3,610 | 0.1% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $126.0K | 7,431 | 0.1% |
| Immatics N.v(IMTX) | SHS | N44445109 | $126.3K | 14,500 | 0.1% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $126.6K | 4,552 | 0.1% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $126.7K | 22,628 | 0.1% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $127.3K | 5,731 | 0.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $127.3K | 3,721 | 0.1% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $127.5K | 40,600 | 0.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $127.9K | 4,911 | 0.1% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $128.7K | 11,982 | 0.1% |